NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY India202037038092Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY European Patent19707555.9Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY China201980012620.8Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Canada3089396Filed on 2019-02-08
NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Read more about NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY Australia2019216781Filed on 2019-02-08
METHODS OF TREATMENTS USING ANTIGEN-BINDING PROTEINS TARGETING CD56 Read more about METHODS OF TREATMENTS USING ANTIGEN-BINDING PROTEINS TARGETING CD56 US Application 16/912,291Filed on 2020-06-25
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Hong Kong42020016865.6Filed on 2020-09-25
Methods of Preparing Anti-human Papillomavirus Antigen T Cells Read more about Methods of Preparing Anti-human Papillomavirus Antigen T Cells Hong Kong42020015851.7Filed on 2020-09-10
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Japan2020-114090Filed on 2020-07-01
MODIFIED CELLS AND METHODS OF THERAPY Read more about MODIFIED CELLS AND METHODS OF THERAPY US Patent 11,266,692Filed on 2020-06-12